Novel Dual-Targeting Antibody Fragment IDB0062 Overcomes Anti–Vascular Endothelial Growth Factor Drug Limitations in Age-Related Macular Degeneration

PURPOSE: Repeated administration of anti–vascular endothelial growth factor drugs to treat age-related macular degeneration leads to resistance. To overcome this drawback, we developed the novel recombinant dual-targeting antibody fragment IDB0062, which is comprised of the anti–vascular endothelial...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seongbeom, Min, Gihong, Kim, Bomin, Lee, Doseop, Lee, Myongjae, Ko, Jong-Hee, Kwon, Hyuk-Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727311/
https://www.ncbi.nlm.nih.gov/pubmed/34967833
http://dx.doi.org/10.1167/tvst.10.14.35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727311/
https://www.ncbi.nlm.nih.gov/pubmed/34967833
http://dx.doi.org/10.1167/tvst.10.14.35

Ejemplares similares